{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T14:44:38Z","timestamp":1793457878632,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/s13075-025-03619-3","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T12:30:50Z","timestamp":1753705850000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Type II diabetes in systemic sclerosis patients: insights from an observational, multicenter study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale)"],"prefix":"10.1186","volume":"27","author":[{"given":"Vasiliki","family":"Liakouli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Forte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Ruscitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Navarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Bellisai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Caso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Guggino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"La Barbera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ada","family":"Corrado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Triggianese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Lo Gullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Mandraffino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Cantarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Frediani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Paolo","family":"Cantatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Sole","family":"Chimenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira","family":"Favoino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Perosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Iagnocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Giacomelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Ciccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"issue":"10373","key":"3619_CR1","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/S0140-6736(22)01692-0","volume":"401","author":"ER Volkmann","year":"2023","unstructured":"Volkmann ER, Andr\u00e9asson K, Smith V. Systemic sclerosis. Lancet. 2023;401(10373):304\u201318.","journal-title":"Lancet"},{"issue":"1","key":"3619_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41584-023-01044-x","volume":"20","author":"V Liakouli","year":"2024","unstructured":"Liakouli V, Ciancio A, Del Galdo F, Giacomelli R, Ciccia F. Systemic sclerosis interstitial lung disease: unmet needs and potential solutions. Nat Rev Rheumatol. 2024;20(1):21\u201332.","journal-title":"Nat Rev Rheumatol"},{"issue":"8","key":"3619_CR3","first-page":"1645","volume":"42","author":"V Liakouli","year":"2024","unstructured":"Liakouli V, Verde I, Ruscitti P, Di Vico C, Ruggiero A, Mauro D, et al. Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano Di Ricerca in reumatologia clinica e Sperimentale). Clin Exp Rheumatol. 2024;42(8):1645\u201355.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"3619_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s43856-023-00429-z","volume":"4","author":"A Ahmad","year":"2024","unstructured":"Ahmad A, Lim LL, Morieri ML, Tam CH, Cheng F, Chikowore T. Precision prognostics for cardiovascular disease in type 2 diabetes: a systematic review and meta-analysis. Commun Med (Lond). 2024;4(1):11.","journal-title":"Commun Med (Lond)"},{"key":"3619_CR5","doi-asserted-by":"publisher","first-page":"e7896","DOI":"10.1097\/MD.0000000000007896","volume":"96","author":"P Ruscitti","year":"2017","unstructured":"Ruscitti P, Ursini F, Cipriani P, Ciccia F, Liakouli V, Carubbi F, et al. Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis: results from a cross-sectional study. Med (Baltim). 2017;96:e7896.","journal-title":"Med (Baltim)"},{"key":"3619_CR6","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1136\/annrheumdis-2011-201176","volume":"71","author":"GS Ngian","year":"2012","unstructured":"Ngian GS, Sahhar J, Proudman SM, Stevens W, Wicks IP, Van Doornum S, et al. Prevalence of coronary heart disease and cardiovascular risk factors in a National cross-sectional cohort study of systemic sclerosis. Ann Rheum Dis. 2012;71:1980\u20133.","journal-title":"Ann Rheum Dis"},{"key":"3619_CR7","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.jbspin.2015.06.017","volume":"83","author":"CC Tseng","year":"2016","unstructured":"Tseng CC, Chang SJ, Tsai WC, Ou TT, Wu Cc, Sung WY, et al. Reduced incidence of type 1 diabetes and type 2 diabetes in systemic sclerosis: A nationwide cohort study. Joint Bone Spine. 2016;83:307\u201313.","journal-title":"Joint Bone Spine"},{"key":"3619_CR8","doi-asserted-by":"crossref","unstructured":"Ursini F, D\u2019Angelo S, Padula A, Gilio M, Russo E, Naty S et al. Retrospective analysis of type 2 diabetes prevalence in a systemic sclerosis cohort from southern Italy: Comment on Reduced incidence of Type 1 diabetes and Type 2 diabetes in systemic sclerosis: A nationwide cohort study by Tseng Joint Bone Spine. 2016;83:307\u2013\u200913. Joint Bone Spine. 2016;83:611-2.","DOI":"10.1016\/j.jbspin.2016.07.006"},{"issue":"3","key":"3619_CR9","doi-asserted-by":"publisher","first-page":"e0283283","DOI":"10.1371\/journal.pone.0283283","volume":"18","author":"J Ciaffi","year":"2023","unstructured":"Ciaffi J, Ruscitti P, Di Cola I, Pavlych V, Italiano N, Gentile M, et al. Whole body insulin sensitivity is increased in systemic sclerosis. PLoS ONE. 2023;18(3):e0283283.","journal-title":"PLoS ONE"},{"key":"3619_CR10","first-page":"e45835","volume":"15","author":"M Zakir","year":"2023","unstructured":"Zakir M, Ahuja N, Surksha MA, Sachdev R, Kalariya Y, Nasir M, et al. Cardiovascular complications of diabetes: from microvascular to macrovascular pathways. Cureus. 2023;15:e45835.","journal-title":"Cureus"},{"key":"3619_CR11","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.3899\/jrheum.150088","volume":"42","author":"P Cipriani","year":"2015","unstructured":"Cipriani P, Di Benedetto P, Ruscitti P, Capece D, Zazzeroni F, Liakouli V, et al. The Endothelial-mesenchymal transition in systemic sclerosis is induced by Endothelin-1 and transforming growth Factor-\u03b2 and May be blocked by macitentan, a dual Endothelin-1 receptor antagonist. J Rheumatol. 2015;42:1808\u201316.","journal-title":"J Rheumatol"},{"key":"3619_CR12","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.phrs.2011.01.012","volume":"63","author":"A Ergul","year":"2011","unstructured":"Ergul A. Endothelin-1 and diabetic complications: focus on the vasculature. Pharmacol Res. 2011;63:477\u201382.","journal-title":"Pharmacol Res"},{"key":"3619_CR13","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1007\/s00125-011-2415-y","volume":"5","author":"A Rafnsson","year":"2012","unstructured":"Rafnsson A, B\u00f6hm F, Settergren M, Gonon A, Brismar K, Pernow J, et al. The endothelin receptor antagonist Bosentan improves peripheral endothelial function in patients with type 2 diabetes mellitus and microalbuminuria: a randomised trial. Diabetologia. 2012;5:600\u20137.","journal-title":"Diabetologia"},{"key":"3619_CR14","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F Van Den Hoogen","year":"2013","unstructured":"Van Den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology\/european league against rheumatism collaborative initiative. Ann Rheum Dis. 2013;72:1747\u201355.","journal-title":"Ann Rheum Dis"},{"key":"3619_CR15","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.2337\/dc09-S013","volume":"32","author":"American Diabetes Association","year":"2009","unstructured":"American Diabetes Association. Standards of medical care in diabetes\u20142009. Diabetes Care. 2009;32:S13\u201361.","journal-title":"Diabetes Care"},{"key":"3619_CR16","doi-asserted-by":"crossref","unstructured":"Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS et al. AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;73:3168\u20133209.","DOI":"10.1016\/j.jacc.2018.11.002"},{"key":"3619_CR17","doi-asserted-by":"crossref","unstructured":"Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute;. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640-5.","DOI":"10.1161\/CIRCULATIONAHA.109.192644"},{"key":"3619_CR18","first-page":"202","volume":"15","author":"EC LeRoy","year":"1988","unstructured":"LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15:202\u20135.","journal-title":"J Rheumatol"},{"key":"3619_CR19","doi-asserted-by":"crossref","unstructured":"Valentini G, Della Rossa A, Bombardieri S, Bencivelli W, Silman AJ, D\u2019Angelo S et al. European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis 200160: 592\u20138.","DOI":"10.1136\/ard.60.6.592"},{"issue":"100","key":"3619_CR20","first-page":"186","volume":"34","author":"K Melsens","year":"2016","unstructured":"Melsens K, De Keyser F, Decuman S, Piette Y, Vandecasteele E, Smith V. Disease activity indices in systemic sclerosis: a systematic literature review. Clin Exp Rheumatol. 2016;34(100):186\u201392.","journal-title":"Clin Exp Rheumatol"},{"key":"3619_CR21","first-page":"S42","volume":"21","author":"TA Medsger","year":"2003","unstructured":"Medsger TA, Bombardieri S, Czirjak L, Scorza R, Della Rossa A, Bencivelli. Assessment of disease severity. J Clin Exp Rheumatol. 2003;21:S42\u20136.","journal-title":"J Clin Exp Rheumatol"},{"key":"3619_CR22","unstructured":"Martinez-Pitre PJ, Sabbula BR, Cascella M, Restrictive Lung D. 2023; In: StatPearls. Treasure Island (FL): StatPearls Publishing."},{"key":"3619_CR23","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.3390\/biomedicines10051168","volume":"10","author":"LV Nedosugova","year":"2022","unstructured":"Nedosugova LV, Markina YV, Bochkareva LA, Kuzina IA, Petunina NA, Yudina IY, et al. Inflammatory mechanisms of diabetes and its vascular complications. Biomedicines. 2022;10:1168.","journal-title":"Biomedicines"},{"key":"3619_CR24","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1093\/qjmed\/hct111","volume":"106","author":"H Penn","year":"2013","unstructured":"Penn H, Quillinan N, Khan K, Chakravarty K, Ong VH, Burns A, et al. Targeting the endothelin axis in scleroderma renal crisis: rationale and feasibility. QJM. 2013;106:839\u201348.","journal-title":"QJM"},{"key":"3619_CR25","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1007\/s00125-011-2415-y","volume":"55","author":"A Rafnsson","year":"2012","unstructured":"Rafnsson A, B\u00f6hm F, Settergren M, Gonon A, Brismar K, Pernow J. The endothelin receptor antagonist Bosentan improves peripheral endothelial function in patients with type 2 diabetes mellitus and microalbuminuria: a randomised trial. Diabetologia. 2012;55:600\u20137.","journal-title":"Diabetologia"},{"key":"3619_CR26","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/nrneph.2012.4","volume":"8","author":"Bosentan improves","year":"2012","unstructured":"Bosentan improves. Endothelial function in diabetes. Nat Rev Nephrol. 2012;8:130.","journal-title":"Nat Rev Nephrol"},{"key":"3619_CR27","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/1752-1947-5-151","volume":"5","author":"F Alvarez Reyes","year":"2011","unstructured":"Alvarez Reyes F, Luna G\u00f3mez C, Brito Su\u00e1rez M. Effect of the dual endothelin receptor antagonist Bosentan on untreatable skin ulcers in a patient with diabetes: a case report. J Med Case Rep. 2011;5:151.","journal-title":"J Med Case Rep"},{"key":"3619_CR28","doi-asserted-by":"publisher","first-page":"1283233","DOI":"10.3389\/fendo.2023.1283233","volume":"14","author":"Gon\u00e7alves Zanotto Tm","year":"2024","unstructured":"Zanotto Tm Gon\u00e7alves, Aess, Saad Mja. Pulmonary hypertension and insulin resistance: a mechanistic overview. Front Endocrinol (Lausanne). 2024;14:1283233.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3619_CR29","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.3390\/diagnostics14111119","volume":"14","author":"O Bruck","year":"2024","unstructured":"Bruck O, Pandit L. Pulmonary hypertension and Hyperglycemia-Not a sweet combination. Diagnostics (Basel). 2024;14:1119.","journal-title":"Diagnostics (Basel)"},{"key":"3619_CR30","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1093\/rheumatology\/kead445","volume":"63","author":"R De Angelis","year":"2024","unstructured":"De Angelis R, Riccieri V, Cipolletta E, Del Papa N, Ingegnoli F, Bosello S, et al. Significant nailfold capillary loss and late capillaroscopic pattern are associated with pulmonary arterial hypertension in systemic sclerosis. Rheumatology (Oxford). 2024;63:616\u20131623.","journal-title":"Rheumatology (Oxford)"},{"key":"3619_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.mvr.2017.03.001","volume":"112","author":"G Maldonado","year":"2017","unstructured":"Maldonado G, Guerrero R, Paredes C, R\u00edos C. Nailfold capillaroscopy in diabetes mellitus. Microvasc Res. 2017;112:41\u20136.","journal-title":"Microvasc Res"},{"key":"3619_CR32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4103\/0970-2113.80314","volume":"8","author":"M Irfan","year":"2011","unstructured":"Irfan M, Jabbar A, Haque As, Awan S, Hussain S. Pulmonary functions in patients with diabetes mellitus. Lung India. 2011;8:89\u201392.","journal-title":"Lung India"},{"key":"3619_CR33","doi-asserted-by":"crossref","unstructured":"Li Y, Liu Y, Liu S, Et. Al. Diabetic vascular diseases: molecular mechanisms and therapeutic strategies. Sig Transduct Target Ther. 2023;8;152.","DOI":"10.1038\/s41392-023-01400-z"},{"key":"3619_CR34","doi-asserted-by":"publisher","first-page":"7","DOI":"10.14336\/AD.2016.0627","volume":"8","author":"H Zheng","year":"2017","unstructured":"Zheng H, Wu J, Jin Z. Potential biochemical mechanisms of lung injury in diabetes. Aging Dis. 2017;8:7\u201316.","journal-title":"Aging Dis"},{"key":"3619_CR35","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3390\/metabo11020069","volume":"11","author":"C Mameli","year":"2021","unstructured":"Mameli C, Ghezzi M, Mari A, Cammi G, Macedoni M, Redaelli FC, et al. The diabetic lung: insights into pulmonary changes in children and adolescents with type 1 diabetes. Metabolites. 2021;11:69.","journal-title":"Metabolites"},{"key":"3619_CR36","doi-asserted-by":"publisher","first-page":"00371","DOI":"10.1183\/23120541.00371-2020","volume":"7","author":"J D\u00edez-Manglano","year":"2021","unstructured":"D\u00edez-Manglano J, As\u00ecn Samper U. Pulmonary function tests in type 2 diabetes: a meta-analysis. ERJ Open Res. 2021;7:00371\u20132020.","journal-title":"ERJ Open Res"},{"key":"3619_CR37","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1055\/s-0034-1372579","volume":"122","author":"H Huang","year":"2014","unstructured":"Huang H, Guo Q, Li L, Lin S, Lin Y, Gong X, et al. Effect of type 2 diabetes mellitus on pulmonary function. Exp Clin Endocrinol Diabetes. 2014;122:322\u20136.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"6","key":"3619_CR38","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1007\/s00125-010-1700-5","volume":"53","author":"A Lecube","year":"2010","unstructured":"Lecube A, Sampol G, Mu\u00f1oz X, Hern\u00e1ndez C, Mesa J, Sim\u00f3 R. Type 2 diabetes impairs pulmonary function in morbidly obese women: a case-control study. Diabetologia. 2010;53(6):1210\u20136.","journal-title":"Diabetologia"},{"key":"3619_CR39","doi-asserted-by":"publisher","first-page":"4765","DOI":"10.2741\/3038","volume":"13","author":"Z Sun","year":"2008","unstructured":"Sun Z, Liu L, Liu N, Liu Y. Muscular response and adaptation to diabetes mellitus. Front Biosci. 2008;13:4765\u201394.","journal-title":"Front Biosci"},{"issue":"1","key":"3619_CR40","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00125-007-0856-0","volume":"51","author":"HJ Kabitz","year":"2008","unstructured":"Kabitz HJ, Sonntag F, Walker D, Schwoerer A, Walterspacher S, Kaufmann S, et al. Diabetic polyneuropathy is associated with respiratory muscle impairment in type 2 diabetes. Diabetologia. 2008;51(1):191\u20137.","journal-title":"Diabetologia"},{"key":"3619_CR41","doi-asserted-by":"publisher","first-page":"765201","DOI":"10.3389\/fendo.2021.765201","volume":"12","author":"S Kopf","year":"2021","unstructured":"Kopf S, Kumar V, Kender Z, Han Z, Fleming T, Herzig S, et al. Diabetic Pneumopathy-A new Diabetes-Associated complication: mechanisms, consequences and treatment considerations. Front Endocrinol (Lausanne). 2021;12:765201.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3619_CR42","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1507\/endocrj.EJ21-0403","volume":"69","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Meng F, Wang M, Li L, Yu P, Jiang Y. Reduced lung function predicts risk of incident type 2 diabetes: insights from a meta-analysis of prospective studies. Endocr J. 2022;69:299\u2013305.","journal-title":"Endocr J"},{"issue":"10","key":"3619_CR43","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1111\/1753-0407.13442","volume":"15","author":"G Lisco","year":"2023","unstructured":"Lisco G, Triggiani V. Computerized nailfold video-capillaroscopy in type 2 diabetes: A cross-sectional study on 102 outpatients. J Diabetes. 2023;15(10):890\u20139.","journal-title":"J Diabetes"},{"key":"3619_CR44","doi-asserted-by":"publisher","first-page":"117955142211228","DOI":"10.1177\/11795514221122828","volume":"15","author":"AE-K Dm","year":"2022","unstructured":"Dm AE-K, Ea H, He H, Ae M, Dm A. Morshedy na. na.l folds capillaries abnormalities associated with type 2 diabetes mellitus progression and correlation with diabetic retinopathy. Clin Med Insights Endocrinol Diabetes. 2022;15:11795514221122828.","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"issue":"3","key":"3619_CR45","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/00045391-200205000-00005","volume":"9","author":"M Signorello Lb","year":"2002","unstructured":"Signorello Lb M, Jk, Lipworth L, Friis S, S\u00f8rensen, Ht. Blot wj. Confounding by indication in epidemiologic studies of commonly used analgesics. Am J Ther. 2002;9(3):199\u2013205.","journal-title":"Am J Ther"},{"issue":"5","key":"3619_CR46","first-page":"1015","volume":"29","author":"N Frederick Wolfe","year":"2002","unstructured":"Frederick Wolfe N, Flowers TA, Burke, Lester M, Arguelles And Dan Pettitt. Increase in lifetime adverse drug reactions, service utilization, and disease severity among patients who will start COX-2 specific inhibitors: quantitative assessment of channeling bias and confounding by indication in 6689 patients with rheumatoid arthritis and osteoarthritis. J Rhuematol. 2002;29(5):1015\u2013102.","journal-title":"J Rhuematol"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03619-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-025-03619-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03619-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T04:26:29Z","timestamp":1757305589000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-025-03619-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3619"],"URL":"https:\/\/doi.org\/10.1186\/s13075-025-03619-3","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,28]]},"assertion":[{"value":"26 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients gave fully informed written consent approved by the institutional ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"157"}}